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ATP-gated P2X2 receptors are widely expressed in neurons, but the
cellular effects of receptor activation are unclear. We engineered
functional green fluorescent protein (GFP)-tagged P2X2 receptors
and expressed them in embryonic hippocampal neurons, and
report an approach to determining functional and total receptor
pool sizes in living cells. ATP application to dendrites caused
receptor redistribution and the formation of varicose hot spots of
higher P2X2-GFP receptor density. Redistribution in dendrites was
accompanied by an activation-dependent enhancement of the
ATP-evoked current. Substate-specific mutant T18A P2X2-GFP re-
ceptors showed no redistribution or activation-dependent en-
hancement of the ATP-evoked current. Thus fluorescent P2X2-GFP
receptors function normally, can be quantified, and reveal the
dynamics of P2X2 receptor distribution on the seconds time scale.
ion channel u ATP u filopodia
Cationic P2X receptors mediate the ‘‘fast’’ milliseconds timescale actions of ATP in the nervous system (1, 2). The
identity of most natively expressed P2X receptors is unclear, but
many neurons express P2X2 mRNA, P2X2 proteins, and func-
tional P2X2-like receptors (2). For example, ATP mediates
synaptic transmission in a portion of CA1 neurons (3), and
postnatal hippocampal neurons express P2X receptors, which
include P2X2 subunits (3–7). Moreover, cytosolic ATP concen-
tration is 1–5 mM, and ATP released during tissue damage
activates neuronal P2X receptors in the periphery (1). ATP
released as a synaptic transmitter and during ischemia of brain
neurons may contribute to pathophysiology, but there are no
available data on the cellular consequences of P2X2 receptor
activation or on the dynamic aspects of P2X2 receptor distribu-
tion in brain neurons.
This study used P2X2 receptors tagged with green fluorescent
protein (GFP) in a quantitative method to study receptors
expressed with recombinant Sindbis virus in embryonic hip-
pocampal neurons. We report (i) the properties of functional
GFP-tagged P2X2 receptors, (ii) an optical and electrophysio-
logical approach to measuring receptor numbers in living cells,
and (iii) the cellular effects of P2X receptor activation.
Materials and Methods
Molecular Biology. By PCR the P2X2 stop codon was removed and
the FLAG (f) epitope was inserted in frame with the P2X2 cDNA
cDNA (9). In the same PCR we inserted an XhoI site in the
DNA. We generated GFP37 (10) with a XhoI site before the start
codon and subcloned it into P2X2-f between the XhoI site 39 of
the FLAG epitope and HindIII in the pcDNA3 polylinker to
yield P2X2-GFP. The P2X2-f-GFP fragment was inserted into
pSinRep5 between the StuI and ApaI sites, and infective Sindbis
particles were generated with the use of the Sindbis Expression
System (http:yywww.invitrogen.comy). Site-directed mutagen-
esis was performed on the cDNAs with the use of synthetic
oligonucleotides to generate K69A and T18A mutants (Quick
Change; Stratagene).
Electrophysiology and Imaging. All cell preparations, two-
electrode voltage-clamp recording of oocytes, and whole-cell
patch recording of hippocampal neurons were performed by
previously described methods (5, 11). Puffs (5 ms) of ATP (100
mM) were applied directly by pressure microejection to den-
drites, soma, or neurites of the cell under voltage clamp (5–20
psi; 1 psi 5 6.89 kPa) from 7- to 10-MV pipettes, with the use
of a Picospritzer II (General Valve, Fairfield, NJ). We imaged
hippocampal neurons with an Olympus Fluoview confocal mi-
croscope and software (http:yywww.olympus.com), but all anal-
ysis was performed with NIH IMAGEJ (http:yyrsb.info.nih.
govyijy) and with the Fluoview software. We used an Olympus
340 oil-immersion objective with a numerical aperture of 1.3.
We applied test solutions to cells during imaging by switching
among an array of parallel quartz tubes (320 mm i.d. and 450 mm
o.d., ending ’0.2 mm from the cell).
Data Analysis. Data were analyzed with CLAMPFIT (Axon Instru-
ments) or ORIGIN 5.0 (Microcal Software, Northampton MA;
http:yywww.MICROCAL.comy). Data in the text and graphs
are shown as mean 6 SEM from n determinations as indicated.
We estimated the size of the somatic compartment by applying
25 mV voltage jumps to neurons under voltage clamp (260 mV)
and with the use of the following relations: Rs 5 dVyIin and Cm
5 tyRs, where Rs is the series resistance, dV is the change in
voltage (5 mV), Iin is the amplitude of the instantaneous current,
Cm is the capacitance, and t is the time constant for the
relaxation of the capacitive transient; we assumed a membrane
capacitance of 0.92 pFy100 mm2 (12). We measured the number
of receptors in the somatic compartment by using the relation I 5
nzizpo, where I is the peak of the macroscopic current, i is the
unitary current at 260 mV (’1 pA), po is the open probability
(0.6), and n is the number of receptors open at the peak (13). For
the optical determination of receptor density the measured pixel
intensity was divided by 4 because the receptors are multimeric
(1) and by 2 because ’50% of the neuron surface is attached to
the glass coverslip; the receptors here are not expected to be
gated by ATP. The adjusted pixel intensity (14) was used to
determine receptor numbers from standard curves (Fig. 2F).
The coefficient of variance 5 SD divided by the mean for n trials,
where the nth trial is at most 20.
Abbreviations: GFP, green fluorescent protein; wt, wild type.
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Results
Properties of P2X2 Receptors Tagged with GFP. We ligated GFP (10)
in frame onto the C terminus of P2X2 receptors (Fig. 1A). When
expressed in Xenopus oocytes, P2X2-GFP and wild-type (wt)
receptors are similar with respect to ATP EC50 (Fig. 1B) peak
currents, desensitization kinetics, and suramin block {ATP EC50
6.5 6 0.9 and 13.5 6 1.5 mM, Hill slopes 1.7 6 0.1 and 2.1 6 0.2,
for wt (n 5 8) and P2X2-GFP receptors (n 5 9); 30 mM suramin
block was 86 6 11% and 91 6 2%, and k11 was 1.2 6 0.4 and
1.2 6 0.2 3 104 M21zs21 for wt (n 5 3) and P2X2-GFP receptors
(n 5 9); where k11 5 1yt[suramin]}. P2X2-GFP receptors also
formed a heteromer with P2X3 (15), as indicated by a slowly
desensitizing response to 10 mM a,b-methylene-ATP, whereas
P2X2-GFP receptors did not respond to this agonist and P2X3
receptors responded with rapidly desensitizing currents (Fig. 1
C–E). Thus wt and P2X2-GFP receptors are similar, with the
exception that P2X2-GFP receptors fluoresce under blue light
and thus provide a noninvasive marker for receptor location in
living cells (Fig. 2).
Density of P2X2-GFP Receptors in Hippocampal Neurons. We used
Sindbis virus constructs (16) to express P2X2-GFP, GFP,
P2X2iresGFP, T18A P2X2-GFP, or K69A P2X2-GFP receptors
in embryonic hippocampal neurons, which are devoid of P2X
receptors at this stage of development (5). Confocal laser
scanning microscopy revealed that expression of P2X2-GFP
resulted in green fluorescence that localized to the plasma
membrane and the cytosol (Fig. 2 A), whereas expression of
P2X2iresGFP resulted in cytosolic green fluorescence (Fig. 2B).
Membrane and cytosolic P2X2-GFP fluorescence was notable in
0.3 mm optical sections (Fig. 2 A), demonstrating that some
P2X2-GFP receptors are cytosolic, as is the case for natively
expressed P2X receptors (17, 18). Capacitance measurements
showed that somatic membrane area was 2449 6 159 mm2 (n 5
36), and by measuring the peak currents evoked by a pulse of 100
Fig. 1. Properties of P2X2-GFP receptors. (A) Diagram of P2X2-GFP receptor
subunit topology. The folds in the extracellular loop represent hypothesized
cysteine-cysteine linkages (1). (B) ATP concentration–effect curves for wt P2X2
and P2X2-GFP receptors. (C–E) Representative ATP and a,b-methylene-ATP-
evoked current waveforms from cells expressing P2X2-GFP (C), P2X3 (D), and
P2X3yP2X2-GFP receptors (E). The ATP-evoked currents desensitized by 16 6
1%, 91 6 1% (t1 5 0.9 6 0.2 s, t2 5 9 6 2 s), and 63 6 3% for P2X2, P2X3, and
P2X3yP2X2-GFP receptors, respectively. The a,b-methylene-ATP-evoked cur-
rents desensitized by 91 6 5% (t1 5 1.0 6 0.1 s, t2 5 13 6 2 s) and 51 6 6% for
P2X3 and P2X3yP2X2-GFP receptors, respectively.
Fig. 2. Quantification of P2X2-GFP receptors in embryonic hippocampal
neurons. (A) (Left) An image through the soma of a neuron expressing
P2X2-GFP receptors. (Right) A confocal stack of 25 optical sections of the same
neuron spaced at 0.3 mm. (B) (Left) An image through the soma of a neuron
expressing GFP from a bicistronic P2X2iresGFP mRNA. (Right) A confocal stack
of 25 optical sections of the same neuron spaced at 0.3 mm. (C) Representative
ATP-evoked current (100 mM, 0.5 s pulse on to soma) shown on double log
scales to show that the peak was calculated at the plateau of the response at
368 ms (peak current 28.5 6 0.5 nA, 10–90% rise time 82 6 20 ms, 90–10%
decay time 2.9 6 0.2 s; n 5 36). (D) The same current waveform as in C, but on
linear scales. (E) Representative current in response to a 5 mV step from 260
mV. The trace was analyzed with the use of an equivalent circuit of the neuron
somatic compartment, where Vp is the pipette potential (260 mV), Rs is the
series resistance (15 6 1 MV), Rm is the membrane resistance (741 6 119 MV),
Vm is the membrane potential, and Cm is the membrane capacitance (24.5 6 1.6
pF; all n 5 36). (F) Standard curve of GFP fluorescence intensity for agarose
beads with various densities of GFP bound to the surface (14). The pixel
intensity is the fluorescence intensity per pixel2 of the bead surface. For high
GFP densities (.100,000 GFP molecules per mm2) the intensity was saturating
and thus measurements were made with a neutral density filter between the
objective and the charge-coupled device, and the absolute values were cor-
rected post hoc (14). (G) Distribution of numbers of P2X2 receptors per mm2.
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mM ATP (28.5 6 0.5 nA; n 5 36, Fig. 2 C and D) we determined
that the Sindbis vector directs the membrane expression of 6.3 6
0.5 P2X2-GFP receptors per mm2 (Fig. 2 G; n 5 36; see Materials
and Methods), thus defining the somatic functional receptor pool
size for these experiments.
We next exploited the fixed stoichiometry between P2X2 and
GFP in the fusion construct and used fluorescence microscopy
to measure the somatic total P2X2-GFP receptor pool size. The
characterization used transparent beads with calibrated surface
densities of GFP quantified with the use of an epifluorescence
microscope (14) (Fig. 2F). We compared the fluorescence
intensity of the soma with the fluorescence intensity per square
micrometer of calibrated bead surface, which served as an
optical standard (14). We found a value of 208 6 14 receptors
per mm2 (n 5 42) for the total somatic receptor pool size (Fig.
2G). Thus most P2X2-GFP receptors are cytosolic, and this pool
may be a source and sink for delivery to the plasma membrane.
ATP-Induced Formation of Varicose P2X2-GFP Hot Spots. We collected
images during a 1–5 min control period, then applied a pulse of
either 100 mM glutamate or 100 mM ATP (10–30 s) and imaged
filopodia with confocal laser scanning microscopy. We observed
no change in the distribution of fluorescence with glutamate
application, but during ATP application some areas increased in
fluorescence; in addition, the apparent size of the fluorescent
area increased within 5–10 s (Fig. 3 A–D). Thus ATP produced
varicose hot spots (Fig. 3 C and D). The formation of varicosities
was supported by similar observations in neurons infected with
P2X2iresGFP (n 5 8), and this provides strong proof for a change
in dendritic morphology. To quantify hot spot size we measured
the intensity of pixels along a control line, during glutamate
application and ATP application. Representative images of
filopodia are shown in Fig. 3 A–C, and normalized plots for 23
line profiles are shown in Fig. 3D. Glutamate caused no change
in the fluorescence profiles, but ATP increased the width of
P2X2-GFP receptor-expressing areas in regions where hot spots
occur (n 5 23). Hot spot width (at the base of the line profiles)
was 1.8 6 0.2 mm initially and 1.8 6 0.2 mm with glutamate, but
2.9 6 0.3 mm after ATP (n 5 23). Thus the ATP-evoked hot
spots in filopodia have a diameter approaching that of the
varicosities, at ’3 mm.
We next chose regions of interest, post hoc, where hot spots
formed de novo. We compared data on regions of interest for 86
hot spots before and during ATP application. On average there
was a net increase in pixel intensity or P2X2-GFP receptors in
regions of interest by 66 6 6% (n 5 86), but pixel intensity
decreased in other nearby areas within the same filopodium (Fig.
3 E and F), and there was no net increase in spatially integrated
intensity (Fig. 3E) over entire dendritic arbors. These data imply
that P2X2-GFP hot spots occur because existing receptors
redistribute during activation (Fig. 3).
Simple ATP-evoked depolarization is not the cause of redis-
tribution because glutamate (100 mM) and KCl (15 mM; data not
shown) did not affect P2X2-GFP distribution (Fig. 3). Further-
more, we observed no ATP-evoked currents or changes in the
distribution of fluorescence in neurons that expressed GFP
alone or mutant K69A P2X2-GFP receptors (see Materials and
Methods; n 5 4, Fig. 4 A and C), in which ATP binding is
disrupted (19). Therefore there are no native ATP receptors that
contribute to either the optical or electrophysiological responses
described in this study. This observation adds credence to the
analysis used to determine receptor numbers (Fig. 2 and Mate-
rials and Methods)
P2X receptors have at least two open states (I1 and I2) that
differ in their permeability to organic cations. The I2 state is
entered in an ATP-dependent manner, has higher permeability
than the I1 state to some cations (5, 11, 20–22), and is absent in
mutant T18A P2X receptors (23) with a disrupted protein kinase
C site in the amino tail (24). In contrast to P2X2-GFP receptors,
mutant T18A P2X2-GFP receptors did not redistribute when
ATP was applied (n 5 11, Fig. 4 B and C). T18A P2X2-GFP
receptors displayed rapidly desensitizing ATP-evoked responses
(n 5 16; .95% desensitization, 90–10% decay time 5 0.9 6 0.1 s,
and 10–90% rise time 5 59 6 14 ms for a 2.5 s 100 mM ATP
pulse; Fig. 4C), whereas P2X2-GFP responses desensitized by
,10% (n 5 5; Fig. 4C). T18A mutant receptors are useful
because they allow P2X2 receptor responses to be assigned to a
particular channel state, and we interpret the rapid desensitiza-
tion kinetics in T18A mutants as indicative of the presence of
only the I1 state (23). Overall these data imply that P2X2-GFP
receptor redistribution and varicosity formation require pro-
longed P2X2 receptor function, for instance, as produced by the
I2 state.
Activation-Dependent Run-Up of the P2X2 Current. Our imaging
experiments show that P2X2-GFP receptor activation causes
redistribution of fluorescence and a change in morphology, but
it remained unclear whether P2X2-GFP receptors move in the
plasma membrane as a result of activation. To address the latter,
we tested electrophysiologically for stimulation-evoked changes
in functional P2X2 receptors by applying ATP briefly (4–10 ms)
to soma and dendrites of hippocampal neurons to approach the
brevity of synaptic ATP release (25).
When ATP was puffed at a frequency of less than 0.1 Hz, the
measured responses differed only slightly from puff to puff by
#10% (the coefficient of variance was 8.9 6 2.2% within a train
of 20 responses at 0.1 Hz, and the peak of the first puff was 560 6
371 pA; n 5 3). But, remarkably, at a frequency of 1 Hz, the
ATP-evoked currents increased in amplitude by 254 6 45% from
290 6 64 pA at the first puff (Fig. 5A; n 5 12 of 15 neurons; three
neurons showed no run-up) of the initial amplitude within 10
responses. The increase could be described by a rate constant of
’0.7 s21 (1yt; Fig. 5B). The coefficient of variance for puffs 1
through 10 was 23.5 6 3.5% (n 5 12), reflecting the activation-
dependent run-up of the ATP-evoked current, but for trials 11
through 20 the coefficient of variance was 5.5 6 2.2% (n 5 12).
Our measurements indicate that ’300 P2X2 receptors are
activated during the first puff and, on average, that the number
of functional receptors doubles within 10 repetitive puffs at 1 Hz.
Run-up was not observed when glutamate was similarly ap-
plied to hippocampal neurons (35 6 13 pA at first puff, n 5 3;
Fig. 5B), when ATP was applied to superior cervical ganglion
neurons (87 6 31 pA at first puff, n 5 5; Fig. 5B), or when ATP
was applied to hippocampal neurons expressing T18A P2X2-
GFP mutant receptors (1018 6 121 pA at first puff; Fig. 5B). We
also examined P2X3 receptors in small-diameter dorsal root
ganglion neurons; as expected, the ATP-evoked currents showed
marked desensitization between trials (26) (426 6 86 pA at first
puff, n 5 15; Fig. 5B). Accepting the limitation that the
glutamate-evoked currents were smaller than the ATP-evoked
currents, we interpret these data to indicate that the ATP
response in hippocampal neurons (Fig. 5A) was not an artifact
of the puffer.
Discussion
The present study shows that P2X2 receptors tagged with GFP
are functional. There were more P2X2-GFP receptors in the cell
than functional receptors in the membrane, and we present an
electrophysiological and optical approach to measuring the
number of functional receptors and the total number of recep-
tors in living cells. We expect that similar approaches that use
calibrated beads (14) as standards can be used to quantify the
expression of any biologically interesting GFP-tagged proteins or
organelles such as synaptic vesicles, in living cells in real time. In
a previous study, P2X1 receptors tagged with GFP on the C
terminus were reported to internalize during ATP applications
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(27). In contrast, we found no evidence for net internalization or
externalization of P2X2-GFP receptors expressed in hippocam-
pal neurons when ATP was applied.
During P2X2-GFP receptor activation by ATP, we observed
(i) the formation of varicose hot spots, (ii) P2X2-GFP redistri-
bution over micrometer distances, and (iii) an activation-
Fig. 3. ATP-dependent redistribution of P2X receptors in hippocampal neurons. (A–C) (Upper) False color images of filopodia from hippocampal neurons
expressing P2X2-GFP. (Lower) Overlay of gray-scale fluorescence and bright-field images. (Left) The control image. (Center) With 100 mM glutamate. (Right) With
100 mM ATP. (D) Twenty-three intensity profiles across filopodia for control, in glutamate, and in the presence of ATP. (E) ATP-evoked changes in integrated pixel
intensity of whole dendritic arbors and regions of interest (ROI’s). (F) Average line profile along 10 hot spots before and during ATP. AU, arbitrary units. Note
the peak of the hot spot has higher fluorescence, but that ’1 mm from the peak, the intensity falls to values lower than in the control.
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dependent enhancement of the ATP-evoked current. We de-
tected a 66% increase in pixel intensity at the most obvious hot
spots after exposure to ATP for 5–10 s. We also detected a 100%
increase in ATP-evoked responses after five puffs at 1 Hz. We
hypothesize that the clustering (Figs. 3C and 5A) evoked by the
addition of ATP underlies the observed increase in responses to
puffs of ATP. There was a difference between the electrophys-
iology and imaging experiments: whereas the activation-
dependent current increase reversed in ’10 s, the increase in
pixel intensity and varicosity formation persisted for at least 5
min. Presumably, changes in dendritic morphology (varicosities)
that are detected optically, but not electrophysiologically, may
explain this difference. Indeed, bright-field images show a
change in morphology, and a similar phenomenon was observed
with P2X2iresGFP, which directs the expression of cytosolic
GFP.
Activation of glutamate receptors results in the formation of
varicosities in neuronal processes (28), and the glutamate re-
ceptor subunit, GluR1, moves from a cytosolic pool to the
plasma membrane during activity in hippocampal neurons (16).
These in vitro studies are enlightening because glutamate-evoked
morphological changes are implicated in the pathogenesis of
ischemic neurotoxicity, and GluR1 redistribution may occur
during synaptic plasticity (16). The present data are portentous
because P2X2 receptor-activation-dependent changes in neuron
morphology and receptor distribution may also occur for natively
expressed receptors in vivo. Indeed, P2X7 receptor-mediated
currents in microglial cells show activation-dependent increases
(29), and activation of P2X7 receptors evokes changes in cell
morphology (30), although changes in P2X7 receptor distribu-
tion were not reported. Moreover, changes in superior cervical
ganglion neuron morphology occur during P2X receptor acti-
vation (11). Interestingly, P2X7 receptors as well as P2X recep-
tors in microglial cells and superior cervical ganglion neurons
display the I2 state. The mechanisms underlying P2X receptor-
mediated changes in cell morphology are currently unknown, but
our data suggest that the higher permeability I2 state of P2X2
receptors is required (5, 11, 20–22) and that perhaps changes
previously associated with P2X7 receptors (30) may also occur
during activation of neuronal P2X receptors. Fluorescence re-
distribution and changes in ATP-evoked currents and morphol-
ogy do not result in cell death because the effects were com-
pletely reversible with the brief (up to 10–30 s) applications
tested in the present study. Moreover, because the T18A muta-
Fig. 4. P2X2-GFP hot spots. (A) Representative examples of dendrites ex-
pressing K69A P2X2-GFP receptors. ATP had no effect compared with the
control. (B) Representative examples of dendrites expressing T18A P2X2-GFP
receptors. ATP had no effect compared with control. (C) (Left) 2.5s 100 mM ATP
application did not evoke any membrane currents from this representative
hippocampal neuron expressing K69A P2X2-GFP receptors. The cells were
healthy because glutamatergic excitatory postsynaptic currents were ob-
served (downward deflections). (Center) 2.5 s 100 mM ATP-evoked currents (5
min apart) from a single hippocampal neuron expressing P2X2-GFP receptors.
The second response was larger than the first (see Fig. 5 for further experi-
ments), and there was ,10% desensitization. (Right) 2.5-s 100 mM ATP-evoked
currents (5 min apart) from a single hippocampal neuron expressing T18A
P2X2-GFP receptors. Note that the second response is smaller than the first (see
also Fig. 5). The traces in Center and Right are normalized to the peak of the
first response.
Fig. 5. Run-up of the P2X receptor current as a function of activation. (A)
Representative whole-cell current recording with ATP puffed every second,
for a total of 20 puffs. We could not reliably apply ATP at frequencies faster
than 1 Hz. (B) Effect of repetitive applications of transmitter to neurons, with
current normalized to the first puff. The ATP-evoked currents in hippocampal
neurons increase as a function of puff number, but glutamate-evoked cur-
rents in hippocampal neurons and ATP-evoked currents in superior cervical
ganglion (SCG) neurons do not. The ATP-evoked currents in dorsal root
ganglion (DRG) neurons show a significant decrease in amplitude as a function
of puff number, as do the ATP-evoked currents at T18A P2X2-GFP receptors.
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tion disrupts the protein kinase C consensus site of P2X2
receptors (24), these data are consistent with, but do not prove,
the idea that P2X2 receptor properties and redistribution may be
shaped by protein kinase C activity.
Native neuronal P2X receptors mediate ATP fast synaptic
transmission in the peripheral, enteric, and central nervous
systems and presynaptically modulate synaptic transmission (1).
In the present paper we have studied P2X2-GFP receptors in
hippocampal neurons because these cells are known to express
P2X2 receptors (17) and ATP mediates a component of the
excitatory postsynaptic current (3). In view of the activation-
dependent nature of the redistribution, P2X2 receptor-mediated
excitatory postsynaptic currents may undergo short-term mod-
ulation, by a postsynaptic mechanism similar to that suggested
for glutamatergic synapses (8, 16, 31, 32). Moreover, P2X
receptor-mediated changes in neuron morphology may be rel-
evant during stroke when ATP is released. Our data establish
redistribution and the formation of varicosities as an interesting
functional attribute of heterologously expressed neuronal P2X2-
GFP receptors. It remains to be determined whether these
effects occur for natively expressed receptors in vivo, either
physiologically or during disease.
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